Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,880 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bioanalysis of therapeutic monoclonal antibody by peptide adsorption-controlled LC-MS.
Hashii N, Tousaka Y, Arai K, Enoki Y, Fukuda S, Goda R, Inoue N, Kawabata M, Murata K, Nakatsuji M, Okuzono T, Shigeyama T, Tachiki H, Yamaguchi T, Yamane S, Yamaoka M, Saito Y, Ishii-Watabe A. Hashii N, et al. Among authors: murata k. Bioanalysis. 2021 Feb;13(4):265-276. doi: 10.4155/bio-2020-0262. Epub 2021 Feb 5. Bioanalysis. 2021. PMID: 33543661
Development and multicenter validation of an LC-MS-based bioanalytical method for antisense therapeutics.
Sun Y, Nitta SI, Saito K, Hosogai R, Nakai K, Goda R, Shimizu H, Fujita H, Kakehi M, Murata K, Yamaguchi T, Okuzono T, Yamane S, Kawabata M, Matsunuma T, Takahara K, Kato N, Yamada M, Yoshida T, Inoue T, Saito Y. Sun Y, et al. Among authors: murata k. Bioanalysis. 2022 Sep;14(18):1213-1227. doi: 10.4155/bio-2022-0126. Epub 2022 Nov 21. Bioanalysis. 2022. PMID: 36408704
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma.
Firestone RS, Socci ND, Shekarkhand T, Zhu M, Ge Qin W, Hultcrantz ML, Mailankody S, Tan CR, Korde N, Lesokhin AM, Hassoun H, Shah UA, Maclachlan KH, Rajeeve S, Landau HJ, Scordo M, Shah GL, Lahoud OB, Giralt SA, Murata K, Usmani SZ, Chung DJ. Firestone RS, et al. Among authors: murata k. Blood. 2024 May 10:blood.2023023557. doi: 10.1182/blood.2023023557. Online ahead of print. Blood. 2024. PMID: 38728378
Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study.
Nakayama Y, Onishi A, Yamamoto W, Yoshikawa A, Shiba H, Yoshida N, Son Y, Shirasugi I, Maeda T, Katsushima M, Hashimoto M, Etani Y, Itami T, Nozaki Y, Onizawa H, Fujii T, Murakami K, Murata K, Tanaka M, Matsuda S, Morinobu A. Nakayama Y, et al. Among authors: murata k. Clin Exp Med. 2024 May 10;24(1):97. doi: 10.1007/s10238-024-01360-w. Clin Exp Med. 2024. PMID: 38727756
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer.
Barcellini A, Murata K, Fontana G, Vai A, Cassani C, Landoni F, Locati LD, Raspagliesi F, Secondino S, Pecorilla M, Yamada S, Okonogi N, Orlandi E. Barcellini A, et al. Among authors: murata k. Clin Transl Radiat Oncol. 2024 Apr 20;47:100781. doi: 10.1016/j.ctro.2024.100781. eCollection 2024 Jul. Clin Transl Radiat Oncol. 2024. PMID: 38726346 Free PMC article.
Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study.
Watanabe R, Ebina K, Gon T, Okano T, Murata K, Murakami K, Maeda Y, Jinno S, Shirasugi I, Son Y, Amuro H, Katayama M, Hara R, Hata K, Yoshikawa A, Yamamoto W, Tachibana S, Hayashi S, Etani Y, Katsushima M, Fukumoto K, Yamada S, Hashimoto M. Watanabe R, et al. Among authors: murata k. Rheumatology (Oxford). 2024 May 9:keae265. doi: 10.1093/rheumatology/keae265. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38724245
3,880 results